Clearmind Medicine (Clearmind Medicine) Other Net Income (Loss) : $-0.00 Mil (TTM As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Other Net Income (Loss)?

Clearmind Medicine's Other Net Income (Loss) for the three months ended in Jan. 2024 was $-0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.00 Mil.

Clearmind Medicine's quarterly Other Net Income (Loss) stayed the same from Jul. 2023 ($0.00 Mil) to Oct. 2023 ($0.00 Mil) but then declined from Oct. 2023 ($0.00 Mil) to Jan. 2024 ($-0.00 Mil).

Clearmind Medicine Other Net Income (Loss) Historical Data

The historical data trend for Clearmind Medicine's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Other Net Income (Loss) Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Other Net Income (Loss)

Get a 7-Day Free Trial

Clearmind Medicine Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Clearmind Medicine Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

Clearmind Medicine Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (Clearmind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

CWY0:Germany CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.